Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Research Abstract |
Intranasal administration of hemagglutinin vaccine with an adjuvant is effective for protection against influenza virus infection. In this study, we found that Kampo medicines, which enhance mucosal immune system, are used for an oral adjuvant. Maoto increased IgA, IgG antibody in bronchoalveolar lavage fluid and serum. Maoto also showed production of virus-specific antibody after intranasal vaccination.
|